By Mike Stobbe
A month after federal officials recommended new versions of COVID-19 vaccines, 7% of U.S. adults and 2% of children have gotten a shot.
One expert called the rates “abysmal.”
The numbers, presented Thursday at a meeting held by the Centers for Disease Control and Prevention, come from a national survey of thousands of Americans, conducted two weeks ago.
The data also indicated that nearly 40% of adults said they probably or definitely will not get the shot. A similar percentage of parents said they did not plan to vaccinate their children.
In the late summer, government health officials made the nation's COVID-19 vaccination campaign more like the annual flu campaign.
Officials approved updated shots that have a single target, an omicron descendant named XBB.1.5. They replaced vaccines that targeted the original coronavirus strain and a much earlier omicron version. Last month, the CDC recommended the new shots for everyone 6 months and older.
The government also transitioned to a commercialized system that relied on the health-care industry — not the government — to handle the distribution of the shots. Many people who immediately went for shots said pharmacies or doctors didn't have them.
Americans have been urged to get different iterations of the vaccines for more than 2/12 years. This year, COVID-19 deaths and hospitalizations fell to lower levels than seen in the previous three years.
Cases remain low compared with the pandemic's early months. Even so, health officials say about 18,000 hospitalization and 1,200 deaths are still being reported each week.
One expert at the meeting, Dr. Camille Kotton of Harvard Medical School, called the numbers “abysmal” and said part of the problem may be patient confusion. She urged stepped-up public education efforts.
Dr. David Kimberlin, of the University of Alabama at Birmingham, also expressed dismay.
“The recommendations are not being heard," he said.
Cheddar's CannaBiz explores the latest trends, politics, and market opportunity in this space. Cheddar Anchor's Brad Smith, Hope King and Alyssa Julya Smith speak with legislators and start-up founders in this emerging market.
This Changes Things: Advice for the executives and leaders of tomorrow, brought to you by American Express OPEN. On Between Bells: The Bachelor finale and big changes at ESPN. With Popular Science, Us Weekly, and more.
His new Amazon bestseller, "The Longevity Diet," helps patients to live longer, healthier and more fulfilling lives by slowing aging, fighting disease and optimizing weight. Dr. Valter Longo sits down with Alyssa Julya Smith in Los Angeles to share some of his secrets to living a healthier life.
Marrying your cousin has long been considered taboo, but new research says that procreating with your cousins may not be as risky as previously thought. Popular Science's Eleanor Cummins breaks down the findings.
Sarah Lewin, associate editor at Space.com, breaks down SpaceX's landmark 50th Falcon 9 launch. The rocket took off early Tuesday morning, launching a communications satellite into orbit.
The Dow closes up more than 300 points as trade war fears subside. Amazon is looking to team up with banks to build a checking account-type product. There's also new speculation on where Amazon's HQ2 might be located. Apple reportedly releasing a cheaper MacBook Air. Former Trump campaign aide refuses to cooperated and the Mueller investigation.
Every three minutes, someone in the U.S. is diagnosed with blood cancer. These people often rely on bone marrow donations to survive, but getting a match can be difficult. To make registering easier, the non-profit DKMS has launched virtual bone marrow drives.
Dina Fine Maron, health & science editor at Scientific American, discusses the breakthrough that could help doctors diagnose mental illnesses. Stem cells have enabled researchers to see how lithium affects the brain.
Eric Harris, president and chief operating officer at Cheddar, joins us to talk about the company's participation in Cycle for Survival, an indoor charity cycling event raising money for rare cancers.
Snap is planning to release new versions of its hugely unpopular Spectacles. The Weinstein Co. lives to fight another day after a last-minute deal emerged Thursday night.
